The rationale for combining GLP-1 receptor agonists with basal insulin. (Record no. 23040723)

MARC details
000 -LEADER
fixed length control field 01476 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516165501.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201311s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1326-5377
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.5694/mja12.11856
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Cohen, Neale D
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20131119
245 00 - TITLE STATEMENT
Title The rationale for combining GLP-1 receptor agonists with basal insulin.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The Medical journal of Australia
Date of publication, distribution, etc. Aug 2013
300 ## - PHYSICAL DESCRIPTION
Extent 246-9 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Blood Glucose
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diabetes Mellitus, Type 2
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Administration Schedule
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy, Combination
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Evidence-Based Medicine
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Glucagon-Like Peptide 1
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hypoglycemic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Insulin, Long-Acting
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Precision Medicine
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Randomized Controlled Trials as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Audehm, Ralph
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pretorius, Elaine
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kaye, Joey
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chapman, Leon H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Colagiuri, Stephen
773 0# - HOST ITEM ENTRY
Title The Medical journal of Australia
Related parts vol. 199
-- no. 4
-- p. 246-9
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.5694/mja12.11856">https://doi.org/10.5694/mja12.11856</a>
Public note Available from publisher's website

No items available.